ғылым
Көрінбейтін жадағайлар, синтетикалық биология, қызықты химия және ғылыми ойдың эволюциясы — бұл бетте ғылымдардың болашағына бағыт беретін тенденциялар мен жаңалықтар қамтылған.
256465
сигналдар
https://www.nature.com/articles/s41598-024-59884-w?code=dcc221e3-6d58-4623-8de1-f3e402b3b9d2&error=cookies_not_supported
сигналдар
табиғат
Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 1059-1064. https://doi.org/10.1093/gerona/61.10.1059 (2006).Article
PubMed
Google Scholar
Janssen, I.,...
PubMed
Google Scholar
Janssen, I.,...
256466
сигналдар
https://www.foxnews.com/health/cancer-trends-revealed-including-common-types-disease-and-biggest-risk-factors
сигналдар
Foxnews
Dr. Marc Siegel reacts to what is behind rising cancer cases among young adults and advises to eat a healthy diet, cut back on alcohol consumption, and get the HPV vaccine Almost 40% of Americans will receive a cancer diagnosis at some point in their lifetime — but certain types are more common...
256467
сигналдар
https://twistedsifter.com/2024/04/could-alzheimers-spread-through-blood-transfusions-new-research-suggests-a-link/
сигналдар
Бұралған сүзгіш
Alzheimer's has one of the biggest research funds of any disease out there, and for good reason. It affects many, and is devastating not only for the people suffering from it, but those who love them. Now, scientists are finding evidence that it could be spread through a simple blood transfusion. Researchers have suspected for a long time that more than genetic factors are at play.
256469
сигналдар
https://www.medpagetoday.com/podcasts/healthwatch/109958
сигналдар
Medpagetoday
THealthWatch - бұл Texas Tech ұсынған апталық подкаст. Онда Элизабет Трейси, Балтимордағы Джонс Хопкинс Медицинасының электронды медиа директоры және Эль Пасодағы Техас Технологиялық Университетінің денсаулық ғылымдары орталығының президенті Рик Лэнге аптаның басты медициналық оқиғаларын қарастырады.
Осы аптаның...
Осы аптаның...
256491
сигналдар
https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-fasenra-copd-approval/
сигналдар
Фармацевтикалық-технология
AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic phenotype, in children aged 6-11 years in more than 80 countries, including the US, EU, and Japan.
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
БОЛАШАҚ Хроника
256490
сигналдар
https://www.beingpatient.com/what-are-biologics-for-alzheimers/
сигналдар
Сабырлы болу
Егер сіз біздің мақалаларымыз бен сұхбаттарымызды пайдалы деп тапсаңыз, біздің қауымдастықтың қолдаушы мүшесі болуды қарастырыңыз. Мидың денсаулығы мен Альцгеймер ауруы туралы редакциялық тәуелсіз ақпарат көзінің жоқтығына ренжіп, біз «Сабырлы болу» журналын құруды шештік. Біз Альцгеймер туралы соңғы зерттеулерді қамтитын арнаулы журналистер тобымыз, сізге сарапшыларға қол жеткізуге мүмкіндік береді және деменциямен өмір сүрудің қандай болатыны туралы пациенттің көзқарасын арттырады.
БОЛАШАҚ Хроника
256489
сигналдар
https://time.com/6972086/ozempic-anti-inflammatory-drug/
сигналдар
уақыт
Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file included descriptions of her initial diagnosis of Crohn's disease as a teenager, the multiple...
БОЛАШАҚ Хроника
256488
сигналдар
https://www.nature.com/articles/d41586-024-01215-0?code=49a116c5-eeb3-4ba2-8fd0-34d9c9e00371&error=cookies_not_supported
сигналдар
табиғат
US drug regulators dropped a bombshell in November 2023 when they announced an investigation into one of the most celebrated cancer treatments to emerge in decades. The US Food and Drug Administration (FDA) said it was looking at whether a strategy that involves engineering a person's immune cells to kill cancer was leading to new malignancies in people who had been treated with it.
БОЛАШАҚ Хроника
256487
сигналдар
https://www.finsmes.com/2024/04/surf-bio-receives-1-6m-non-dilutive-grant-from-bill-melinda-gates-foundation.html
сигналдар
Фисмалар
Surf Bio Receives $1.6M Non-Dilutive Grant From Bill & Melinda Gates Foundation
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Компания ниеті...
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Компания ниеті...
БОЛАШАҚ Хроника
256486
сигналдар
https://www.finsmes.com/2024/04/enlaza-therapeutics-raises-100m-in-series-a-financing.html
сигналдар
Фисмалар
Enlaza Therapeutics, a La Jolla, CA-based covalent biologic platform company, raised $100M in Series A funding.
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
БОЛАШАҚ Хроника
256485
сигналдар
https://www.statnews.com/2024/04/30/economics-holding-back-promise-antibody-therapies-infectious-diseases/
сигналдар
Statnews
Next-generation broadly neutralizing antibodies (bnAbs) have the potential to transform the fight against global health threats like HIV, malaria, and Ebola. The commercialization of these innovative antibody therapies could save millions of lives annually. But turning promise into reality...
256468
сигналдар
https://www.cnbc.com/2024/05/05/within-a-few-years-generative-ai-will-design-new-drugs-on-its-own.html
сигналдар
cnbc
The advances related to AI are taking place within a field of biology that has been increasingly digitized at what Powell describes as "unprecedented scales and resolutions." It's a medical revolution that includes spatial genomics scanning millions of cells within tissue, in 3-and AI model-building that specifically benefits from a catalog of chemicals already in a digital form which allows generative AI transformer models to now go to work on them.
256484
сигналдар
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-announces-promising-findings-in-phase-2b3-clinical-trial-of-nrx-101-vs-lurasidone-for-treatment-of-suicidal-bipolar-depression-302131482.html
сигналдар
Prnewswire
NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia relative to lurasidone - never previously shown with an oral antidepressant. Suicidality signal met the...
256483
сигналдар
https://www.fda.gov/news-events/press-announcements/fda-roundup-april-30-2024
сигналдар
FDA
Дереу шығарылым үшін:
Сәуір 30, 2024
Бүгін АҚШ-тың Азық-түлік және дәрі-дәрмек басқармасы агенттіктегі жаңалықтардың қысқаша мазмұнын ұсынады:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
Сәуір 30, 2024
Бүгін АҚШ-тың Азық-түлік және дәрі-дәрмек басқармасы агенттіктегі жаңалықтардың қысқаша мазмұнын ұсынады:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
256482
сигналдар
https://www.cnbc.com/2024/05/01/healthy-returns-humira-sales-are-falling-but-abbvie-has-successors.html
сигналдар
cnbc
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Sales of 's Humira are plummeting as the once-top-selling drug fights competition from cheaper biosimilars in the U.and abroad. . That was clear after AbbVie on Friday reported first-quarter revenue and adjusted profit that topped Wall Street's expectations, partly driven by strength in the drugmaker's immunology business.
256481
сигналдар
https://www.csrwire.com/press_releases/800871-jazz-pharmaceuticals-focuses-taking-actions-positively-impact-planet-earth
сигналдар
Csrwire
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology.
256471
сигналдар
https://www.forbes.com/sites/joshuacohen/2024/05/03/medicare-says-it-expects-to-spend-35-billion-in-2025-on-alzheimers-drug-leqembi-but-this-is-unlikely/
сигналдар
Forbes
ABINGTON, PA - NOV 7: Nurse Christine Besso, center, helps Robert Williford, 66, left, during his ... [+] first session of receive the newly FDA approved Alzheimer's treatment Leqembi while Williford's wife Cynthia Byron-Williford, 59, right, watches at Abington Neurological Associates in...
256473
сигналдар
https://www.jmir.org/2024/1/e48572/
сигналдар
Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study
Джмир
Introduction In recent years, the issue of drug toxicity has emerged as a serious concern in the fields of clinical medicine, pharmacology, and sociology. As a result, drug regulatory agencies worldwide are making continuous efforts to monitor marketed drugs and assess their potential risks in...
256472
сигналдар
https://www.finsmes.com/2024/05/latus-raises-54m-in-series-a-financing.html
сигналдар
Фисмалар
Latus Bio, a Philadelphia, PA-based biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), raised $54M in Series A funding.
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
256479
сигналдар
https://www.healio.com/news/dermatology/20240501/eli-lillys-firstquarter-financial-results-highlight-resubmission-of-bla-for-lebrikizumab
сигналдар
Халио
Мамыр 01, 2024
1 мин оқылды
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Электрондық пошта ескертулеріне тақырып қосыңыз
Электрондық пошта ескертулеріне қосылды
Сұрауыңызды өңдеу мүмкін болмады. Тағы жасауды сәл кейінірек көріңізді өтінеміз. Егер де сен...
1 мин оқылды
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Электрондық пошта ескертулеріне тақырып қосыңыз
Электрондық пошта ескертулеріне қосылды
Сұрауыңызды өңдеу мүмкін болмады. Тағы жасауды сәл кейінірек көріңізді өтінеміз. Егер де сен...
256470
сигналдар
https://www.startribune.com/thousands-believe-covid-vaccines-harmed-them-is-anyone-listening/600363571/
сигналдар
Startribune
Within minutes of getting the Johnson & Johnson COVID-19 vaccine, Michelle Zimmerman felt pain racing from her left arm up to her ear and down to her fingertips. Within days, she was unbearably sensitive to light and struggled to remember simple facts. She was 37, with a doctorate in neuroscience, and until then could ride her bicycle 20 miles, teach a dance class and give a lecture on artificial intelligence, all in the same day.
256480
сигналдар
https://www.pharmaceutical-technology.com/news/enlaza-series-a-funding/
сигналдар
Фармацевтикалық-технология
Enlaza Therapeutics has raised $100m in a Series A financing round headed by the Life Sciences group of JP Morgan Asset Management's private capital division.
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...